Omeprazole Teva

Omeprazole, the active ingredient in Omeprazole Teva, is a Proton Pump Inhibitor presented as a 20 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and children.

GNH USA supplies Omeprazole Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole Teva is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑esophageal reflux disease (GERD): alleviates heartburn and promotes healing of the esophageal lining. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid production. - Erosive esophagitis: aids mucosal healing and symptom relief. - Helicobacter pylori eradication regimens: used as adjunct therapy to improve eradication rates.

Omeprazole may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild, transient headache reported in some patients. - Diarrhea: loose stools occurring during early treatment. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach area. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis linked to altered gut flora. - Vitamin B12 deficiency: long‑term use may impair absorption. - Hypomagnesemia: low magnesium levels with prolonged therapy. - Fracture risk: possible increase in hip, wrist or spine fractures with extended use. - Acute interstitial nephritis: rare kidney inflammation. - Stevens‑Johnson syndrome: extremely rare severe skin reaction.

When using Omeprazole Teva, consider the following safety measures: - Assess renal function: adjust use in patients with severe kidney impairment. - Evaluate hepatic status: use cautiously in moderate to severe liver disease. - Review long‑term therapy: monitor for nutrient deficiencies and bone health. - Pregnancy and lactation: weigh benefits against potential risks; consult a healthcare professional. - Concomitant medications: check for possible drug‑drug interactions before initiating therapy. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazole can interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Clopidogrel: omeprazole may reduce antiplatelet activation. - Atazanavir: decreased absorption of the antiviral. - Dasatinib: reduced plasma concentrations.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR values. - Phenytoin: possible reduction in phenytoin levels. - Methotrexate: enhanced systemic exposure, especially at high doses. - Digoxin: modest increase in serum digoxin concentrations.